DANIEL JANNEY
CIK 1198325 · last filed 2026-03-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$79.71M
Companies
11
Total Filings
72
Lifetime Open-Market Net
-$107.45M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KRYS | Director | 74,036 | $317.97 | $23.54M | -$42.01M | 16 | 2026-03-03 |
| Allakos Inc. (ALLK) Delisted | Director | 6,448,053 | $0.33 | $2.12M | $1.22M | 11 | 2023-05-30 |
| ESPR | Director | 48,014 | $3.15 | $151.2K | -$2.73M | 11 | 2021-05-28 |
| STRO | Director | 1,944,901 | $28.80 | $56.01M | $0 | 3 | 2019-06-19 |
| VIVE | Director | 1,442,534 | $0.00 | $289 | $3.00M | 16 | 2019-01-02 |
| VIVEVE MEDICAL, INC. (TCON) Delisted | Director | 5,455,632 | $0.03 | $175.7K | $1.60M | 4 | 2016-01-29 |
| Evofem Biosciences, Inc. (NEOT) Delisted | Director | 1,589,776 | — | — | -$6.01M | 2 | 2015-12-30 |
| ZS Pharma, Inc. (ZSPH) Delisted | 10%+ Owner | 2,646,643 | — | — | -$50.75M | 1 | 2015-06-09 |
| ELLIE MAE INC (ELLI) Delisted | 10%+ Owner | 3,364,708 | — | — | -$11.77M | 1 | 2011-04-21 |
| ANESIVA, INC. (ANSV) Delisted | Director | 6,172,840 | — | — | $0 | 3 | 2008-05-12 |
| COTHERIX INC (CTRX) Delisted | Director | — | — | — | $0 | 1 | 2007-01-05 |
Recent Filings · Page 2 of 8
72 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-09-23 | Allakos Inc. (ALLK) Delisted | Buy (P) | +475,000 | $2.38M | EDGAR |
| 2022-07-01 | KRYS | Grant (A) | — | $0 | EDGAR |
| 2022-05-27 | Allakos Inc. (ALLK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-14 | KRYS | Sell (S) | −100,000 | -$7.05M | EDGAR |
| 2021-10-14 | Allakos Inc. (ALLK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-07-02 | KRYS | Grant (A) | — | $0 | EDGAR |
| 2021-05-28 | ESPR | Grant (A) | +12,376 | $0 | EDGAR |
| 2021-03-30 | Allakos Inc. (ALLK) Delisted | Sell (S) | −17,308 | -$1.99M | EDGAR |
| 2021-03-24 | Allakos Inc. (ALLK) Delisted | Sell (S) | −13,148 | -$1.57M | EDGAR |
| 2021-03-16 | Allakos Inc. (ALLK) Delisted | Sell (S) | −10,779 | -$1.34M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.